In vivo experiments and the levels of MMP-9 and TIMP-1 in serum and the infarcted cortex were determined through multiple strategies, including ELISA, immunohistochemistry, RT-PCR, and Western blotting, which were the key factors closely related to BBB injury in ischemic stroke. This evidence concerns the gene TIMP1 and ischemic stroke.